Estrogen and Progesterone Receptor Expression in Endometrioid Endometrial Carcinomas: A Clinicopathological Study

Estrogen and Progesterone Receptor Expression in Endometrioid Endometrial Carcinomas: A Clinicopathological Study

Background: This study assesses the expressions of estrogen and progesterone receptors in endometrioid carcinomas of the endometrium and their association with established clinicopathological prognostic parameters. Methods: We reviewed the pathology and medical records from 45 cases of endometr...

Full description

Bibliographic Details
Main Authors:	Indu Maniketh, Gayatri Ravikumar, Julian A. Crasta, Rekha Prabhu, Elizabeth Vallikad
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2014-03-01
Series:	Middle East Journal of Cancer
Subjects:	Endometrial carcinoma Hormone receptors Prognostic factors
Online Access:	http://mejc.sums.ac.ir/index.php/mejc/article/view/159/122

Similar Items

Immunohistochemical expression of estrogen and progesterone receptors in endometrial hyperplasia and endometrioid carcinoma
by: Sarmadi S, et al.
Published: (2012-06-01)

Endometrial expression of e-cadherin in relation to estrogen-progesterone receptor characteristics of the endometrium
by: S. S. Aganezov, et al.
Published: (2020-07-01)

Clinicopathological correlation of endometrial hyperplasias with progesterone receptor expression in DUB
by: G V Neethu, et al.
Published: (2023-01-01)

Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer
by: Ren S, et al.
Published: (2020-12-01)

Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancer
by: Mi-Kyung Kim, et al.
Published: (2023-09-01)

Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors
by: Luis Fernando Méndez-López, et al.
Published: (2016-12-01)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
by: Dan Kuai, et al.
Published: (2023-07-01)

Overexpression of estrogen and progesterone receptors as indicator of endometrial receptivity disorder in women with early miscarriage
by: Sergey S. Aganezov, et al.
Published: (2020-06-01)

PTEN Immunoexpression in Atypical Endometrial Hyperplasia and Endometrioid Endometrial Carcinoma: A Research Protocol
by: Garima Akhil chandrakar, et al.
Published: (2023-07-01)

The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer
by: Fariba Yarandi, et al.
Published: (2023-03-01)

Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma
by: Kathleen Lundeberg, et al.
Published: (2024-06-01)

Residual Disease after Operative Hysteroscopy in Patients with Endometrioid Endometrial Cancer Associated with Polyps
by: Marcelo Simonsen, et al.
Published: (2021-03-01)

The Effect of Medroxy Progesterone Acetate Hormone Administration to Endometrial Thickness of the Female Rattus norvegicus Wistar strain
by: Devi Yulita
Published: (2020-06-01)

Association of estrogen and progesterone receptors with clinicopathological prognostic factors in breast cancer
by: Ali Abdul Hadi Abdul-Kareem, et al.
Published: (2021-01-01)

Exploring the Prognostic and Predictive Roles of Ki-67 in Endometrial Cancer
by: Laura Paleari, et al.
Published: (2023-11-01)

New Insights into Breast and Endometrial Cancers
by: Yasuhiro Miki
Published: (2020-09-01)

Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
by: Peng Jiang, et al.
Published: (2021-08-01)

FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features
by: Dae Hyun Song, et al.
Published: (2023-12-01)

Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer
by: Ju-Hyun Kim, et al.
Published: (2022-05-01)

Estrogen Receptor (ER) and Progesterone Receptor (PgR) Expression in Endometrial Cancer—An Immunohistochemical Assessment
by: Stanisław Przewoźny, et al.
Published: (2024-02-01)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
by: Lenka Kalinkova, et al.
Published: (2020-08-01)

Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients
by: Gulzhanat Aimagambetova, et al.
Published: (2021-12-01)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
by: Jun Guan, et al.
Published: (2022-10-01)

Expression Pattern of Leptin and Its Receptors in Endometrioid Endometrial Cancer
by: Dariusz Boroń, et al.
Published: (2021-06-01)

An integrated prediction model of recurrence in endometrial endometrioid cancers
by: Miller MD, et al.
Published: (2019-06-01)

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer
by: Bozena Dobrzycka, et al.
Published: (2010-04-01)

The role of estrogen and progesterone receptors in response rate to megestrol acetate: conservative treatment of stage Ia endometrial adenocarcinoma
by: Yarandi F, et al.
Published: (2010-12-01)

To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma
by: Anuja Yadav, et al.
Published: (2024-01-01)

Endometrial expression of leukemia inhibitory factor in women with different estrogen/progesterone receptor status of the endometrium
by: S. S. Aganezov, et al.
Published: (2019-07-01)

Benefits of Levonorgestrel Intrauterine Device Use vs. Oral or Transdermal Progesterone for Postmenopausal Women Using Estrogen Containing Hormone Therapy
by: Kaylee Clark, et al.
Published: (2019-07-01)

Endometrial hyperplasia and progesterone resistance: a complex relationship
by: Mekan R. Orazov, et al.
Published: (2023-03-01)

p53, estrogen and progesterone receptors in diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy
by: Vera Lúcia Leite Bonfitto, et al.

Microsatellite Instability in Young Women with Endometrioid type Endometrial Cancer
by: MR Abbaszadegan, et al.
Published: (2009-09-01)

Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma
by: Sujin Park, et al.
Published: (2021-08-01)

Thrombocytosis as a Biomarker in Type II, Non-Endometrioid Endometrial Cancer
by: Parker Bussies, et al.
Published: (2020-08-01)

Non-endometrioid endometrial cancer: Analysis of different adjuvant treatment modalities
by: Gonçalo Nogueira-Costa, et al.
Published: (2022-01-01)

Recurrence Pattern after Adjuvant Radiotherapy for Endometrioid Type Endometrial Cancer
by: Yasin Durmus, et al.
Published: (2018-08-01)

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence
by: Jesus Gonzalez-Bosquet, et al.
Published: (2022-12-01)

Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma
by: Asmerom T Sengal, et al.
Published: (2022-11-01)

Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
by: Mathilde Mairé, et al.
Published: (2022-04-01)